Post-market Review Reference Groups

Department of Health
The Department of Health have approached CHF to nominate to the following to expert reference groups: • Expert Reference group for the Post-market Review of Pulmonary Arterial Hypertension (PAH) Medicines • Expert Reference group for the Post-market Review of biological Disease Modifying Anti-Rheumatic Drugs (bDMARDs) to treat Severe Chronic Plaque Psoriasis
Deadline: 
24 March 2017